To understand the difference between EssilorLuxottica (ESLOF) vs. EssilorLuxottica - ADR (ESLOY) it is enough to know the definitions of ADR
ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ESLOF’s FA Score shows that 3 FA rating(s) are green whileESLOY’s FA Score has 3 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ESLOF’s TA Score shows that 3 TA indicator(s) are bullish while ESLOY’s TA Score has 3 bullish TA indicator(s).
ESLOF (@Pharmaceuticals: Other) experienced а -3.63% price change this week, while ESLOY (@Pharmaceuticals: Other) price change was -3.34% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.10%. For the same industry, the average monthly price growth was +5.06%, and the average quarterly price growth was +21.78%.
ESLOY is expected to report earnings on Oct 16, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
ESLOF | ESLOY | ESLOF / ESLOY | |
Capitalization | 142B | 142B | 100% |
EBITDA | 6.71B | 6.71B | 100% |
Gain YTD | 28.158 | 32.927 | 86% |
P/E Ratio | 51.48 | 51.90 | 99% |
Revenue | 27.2B | 27.2B | 100% |
Total Cash | 3.16B | 3.16B | 100% |
Total Debt | 14B | 14B | 100% |
ESLOF | ESLOY | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 78 | 6 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 33 Fair valued | 33 Fair valued | |
PROFIT vs RISK RATING 1..100 | 22 | 15 | |
SMR RATING 1..100 | 95 | 95 | |
PRICE GROWTH RATING 1..100 | 47 | 47 | |
P/E GROWTH RATING 1..100 | 26 | 27 | |
SEASONALITY SCORE 1..100 | 85 | 4 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ESLOF's Valuation (33) in the null industry is in the same range as ESLOY (33). This means that ESLOF’s stock grew similarly to ESLOY’s over the last 12 months.
ESLOY's Profit vs Risk Rating (15) in the null industry is in the same range as ESLOF (22). This means that ESLOY’s stock grew similarly to ESLOF’s over the last 12 months.
ESLOY's SMR Rating (95) in the null industry is in the same range as ESLOF (95). This means that ESLOY’s stock grew similarly to ESLOF’s over the last 12 months.
ESLOY's Price Growth Rating (47) in the null industry is in the same range as ESLOF (47). This means that ESLOY’s stock grew similarly to ESLOF’s over the last 12 months.
ESLOF's P/E Growth Rating (26) in the null industry is in the same range as ESLOY (27). This means that ESLOF’s stock grew similarly to ESLOY’s over the last 12 months.
ESLOF | ESLOY | |
---|---|---|
RSI ODDS (%) | 1 day ago61% | 1 day ago56% |
Stochastic ODDS (%) | 1 day ago63% | 1 day ago51% |
Momentum ODDS (%) | 1 day ago68% | 1 day ago65% |
MACD ODDS (%) | 1 day ago57% | 1 day ago48% |
TrendWeek ODDS (%) | 3 days ago53% | 3 days ago50% |
TrendMonth ODDS (%) | 1 day ago62% | 1 day ago53% |
Advances ODDS (%) | 11 days ago65% | 9 days ago59% |
Declines ODDS (%) | 1 day ago54% | 1 day ago50% |
BollingerBands ODDS (%) | 1 day ago61% | 1 day ago49% |
Aroon ODDS (%) | 3 days ago59% | 3 days ago50% |
A.I.dvisor indicates that over the last year, ESLOF has been loosely correlated with ESLOY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOF jumps, then ESLOY could also see price increases.
Ticker / NAME | Correlation To ESLOF | 1D Price Change % | ||
---|---|---|---|---|
ESLOF | 100% | -1.69% | ||
ESLOY - ESLOF | 58% Loosely correlated | -0.15% | ||
SAUHF - ESLOF | 39% Loosely correlated | -3.68% | ||
SMMNY - ESLOF | 32% Poorly correlated | -0.28% | ||
NVCR - ESLOF | 27% Poorly correlated | +0.68% | ||
MASS - ESLOF | 24% Poorly correlated | -1.10% | ||
More |
A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.
Ticker / NAME | Correlation To ESLOY | 1D Price Change % | ||
---|---|---|---|---|
ESLOY | 100% | -0.15% | ||
ESLOF - ESLOY | 58% Loosely correlated | -1.69% | ||
QGEN - ESLOY | 43% Loosely correlated | -1.78% | ||
ALC - ESLOY | 38% Loosely correlated | -0.11% | ||
SMMNY - ESLOY | 38% Loosely correlated | -0.28% | ||
CRL - ESLOY | 35% Loosely correlated | -0.56% | ||
More |